Skip to main content
Premium Trial:

Request an Annual Quote

PacBio Receives $10M Milestone Payment from Roche

NEW YORK (GenomeWeb) – Pacific Biosciences has received a $10 million payment from Roche for hitting a development milestone that is part of the commercialization and license agreement the companies struck in 2013, according to a PacBio filing with the US Securities and Exchange Commission.

PacBio didn't disclose what development milestone had been met, but noted that it may receive up to $30 million in the future for reaching additional development milestones. It said that the payment will be recorded as contractual revenue in its third quarter financial statement.

In September 2013, Roche and PacBio entered into an agreement under which PacBio will supply Roche with sequencing systems and consumables for diagnostic purposes based on its SMRT platform. Roche will have global rights to exclusively distribute the products in the field of human in vitro diagnostics.

PacBio received an upfront payment of $35 million, and an additional $40 million in funding was tied to development milestones.

The agreement has an initial term of 13 years with provisions that allow Roche to renew it in 5-year increments, according to the document.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.